Related Experiment Video
Updated: Apr 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Structural basis of how stress-induced MDMX phosphorylation activates p53
1Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract:
The tumor-suppressor protein p53 is tightly controlled in normal cells by its two negative regulators--the E3 ubiquitin ligase MDM2 and its homolog MDMX. Under stressed conditions such as DNA damage, p53 escapes MDM2- and MDMX-mediated functional inhibition and degradation, acting to prevent damaged cells from proliferating through induction of cell cycle arrest, DNA repair, senescence or apoptosis. Ample evidence suggests that stress signals induce phosphorylation of MDM2 and MDMX, leading to p53 activation. However, the structural basis of stress-induced p53 activation remains poorly understood because of the paucity of technical means to produce site-specifically phosphorylated MDM2 and MDMX proteins for biochemical and biophysical studies. Herein, we report total chemical synthesis, via native chemical ligation, and functional characterization of (24-108)MDMX and its Tyr99-phosphorylated analog with respect to their ability to interact with a panel of p53-derived peptide ligands and PMI, a p53-mimicking but more potent peptide antagonist of MDMX, using FP and surface plasmon resonance techniques. Phosphorylation of MDMX at Tyr99 weakens peptide binding by approximately two orders of magnitude. Comparative X-ray crystallographic analyses of MDMX and of pTyr99 MDMX in complex with PMI as well as modeling studies reveal that the phosphate group of pTyr99 imposes extensive steric clashes with the C-terminus of PMI or p53 peptide and induces a significant lateral shift of the peptide ligand, contributing to the dramatic decrease in the binding affinity of MDMX for p53. Because DNA damage activates c-Abl tyrosine kinase that phosphorylates MDMX at Tyr99, our findings afford a rare glimpse at the structural level of how stress-induced MDMX phosphorylation dislodges p53 from the inhibitory complex and activates it in response to DNA damage.
Insights
Stress-induced phosphorylation of MDMX at Tyr99 weakens its binding to p53. This structural insight explains how MDMX releases p53, activating its tumor-suppressor function after DNA damage.
Area of Science:
- Molecular Biology
- Structural Biology
- Cancer Research
Background:
- The tumor suppressor p53 is regulated by MDM2 and MDMX.
- Stress signals, like DNA damage, activate p53 by phosphorylating MDM2 and MDMX.
- The structural basis for this activation is unclear due to challenges in studying phosphorylated proteins.
Purpose of the Study:
- To investigate the structural mechanism of stress-induced p53 activation.
- To synthesize and characterize phosphorylated MDMX for biochemical studies.
Main Methods:
- Total chemical synthesis of MDMX and its Tyr99-phosphorylated form.
- Functional characterization using peptide binding assays (FP, SPR).
- X-ray crystallography and molecular modeling.
Main Results:
- Phosphorylation of MDMX at Tyr99 significantly reduces its binding affinity for p53 peptides and PMI.
- Structural analysis reveals steric clashes and peptide displacement caused by the phosphate group.
- This explains how MDMX releases p53 upon DNA damage.
Conclusions:
- Stress-induced phosphorylation of MDMX at Tyr99 is a key mechanism for p53 activation.
- Structural insights clarify how MDMX releases p53, enabling its tumor-suppressive functions.
- Findings provide a structural basis for understanding p53 regulation in cancer.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway

